首页> 外文期刊>Neuropharmacology >Possible involvement of serotonin 5-HT2 receptor in the regulation of feeding behavior through the histaminergic system.
【24h】

Possible involvement of serotonin 5-HT2 receptor in the regulation of feeding behavior through the histaminergic system.

机译:血清素5-HT2受体可能参与通过组胺能系统调节进食行为。

获取原文
获取原文并翻译 | 示例
           

摘要

The central histaminergic system has been proven to be involved in several physiological functions including feeding behavior. Some atypical antipsychotics like risperidone and aripiprazole are known to affect feeding behavior and to antagonize the serotonin (5-HT) receptor subtypes. To examine the possible neural relationship between the serotonergic and histaminergic systems in the anorectic effect of the antipsychotics, we studied the effect of a single administration of these drugs on food intake and hypothalamic histamine release in mice using in vivo microdialysis. Single injection of risperidone (0.5mg/kg, i.p.) or aripiprazole (1mg/kg, i.p.), which have binding affinities to 5-HT(1A, 2A, 2B) and (2C) receptors decreased food intake in C57BL/6N mice with concomitant increase of hypothalamic histamine release. However, a selective D(2)-antagonist, haloperidol (0.5mg/kg, i.p.), did not have effects on food intake or histamine release. Furthermore, in histamine H(1) receptor-deficient mice, there was no reduction of food intake induced by atypical antipsychotics, although histamine release was increased. Moreover, selective 5-HT(2A)-antagonists, volinanserin (0.5, 1mg/kg, i.p.) and ketanserin (5, 10mg/kg, i.p.), significantly increased histamine release and 5-HT(2B/2C) -antagonist, SB206553 (2.5, 5mg/kg, i.p.), slightly increased it. On the contrary, 5-HT(1A) -selective antagonist, WAY100635 (1, 2mg/kg), did not affect the histaminergic tone. These findings suggest that serotonin tonically inhibits histamine release via 5-HT(2) receptors and that antipsychotics enhance the release of hypothalamic histamine by blockade of 5-HT(2) receptors resulting in anorexia via the H(1) receptor.
机译:中央组胺能系统已被证明参与多种生理功能,包括进食行为。已知一些非典型抗精神病药,如利培酮和阿立哌唑会影响进食行为并拮抗5-羟色胺(5-HT)受体亚型。若要检查抗精神病药的厌食作用中血清素能和组胺能系统之间可能的神经关系,我们研究了使用体内微透析对这些药物的单次给药对小鼠食物摄入和下丘脑组胺释放的影响。单次注射利培酮(0.5mg / kg,ip)或阿立哌唑(1mg / kg,ip),它们与5-HT(1A,2A,2B)和(2C)受体具有结合亲和力,从而降低了C57BL / 6N小鼠的摄食量与下丘脑组胺释放同时增加。但是,选择性D(2)拮抗剂氟哌啶醇(0.5mg / kg,腹腔注射)对食物摄入或组胺释放没有影响。此外,在组胺H(1)受体缺陷型小鼠中,尽管组胺释放增加,但非典型抗精神病药诱导的食物摄入量没有减少。此外,选择性5-HT(2A)拮抗剂,volansanserin(0.5,1mg / kg,ip)和ketanserin(5,10mg / kg,ip)显着增加组胺释放和5-HT(2B / 2C)拮抗剂, SB206553(2.5,5mg / kg,ip),略微增加。相反,5-HT(1A)选择性拮抗剂WAY100635(1,2mg / kg)不会影响组胺能。这些发现表明,5-羟色胺通过5-HT(2)受体抑制了组胺的释放,抗精神病药通过阻断5-HT(2)受体而导致下丘脑组胺的释放,从而导致通过H(1)受体的厌食。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号